Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens
- PMID:24748765
- PMCID: PMC3986296
- DOI: 10.2147/OPTH.S59878
Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens
Abstract
Purpose: To evaluate the incidence rate and indications for explantation of Verisyse phakic intraocular lenses (pIOLs) over a 13.6 year period.
Subjects and methods: Case series describing six cases of explantation of Verisyse pIOLs, out of 213 eyes with Verisyse pIOLs, implanted over a 13.6 year period by one surgeon at one institution, with mean follow-up of 5.6 years per eye.
Results: Four pIOLs were removed to facilitate extraction of a visually significant cataract, one was removed due to both cataract formation and development of corneal decompensation, and another was removed due to development of localized peripheral corneal decompensation. The incidence rate of pIOL removal was five per 1,000 patient-years with pIOL. Mean time from insertion of pIOL to cataract removal was 9.3 years (range 4.0-12.6 years). Mean time from insertion of pIOL to development of corneal decompensation was 10 years (range 6.9-13 years). There was no increase in the rate of cataract extraction in the pIOL population compared to the general population.
Conclusion: Cataracts may develop in patients with pIOLs, necessitating removal of the pIOL. Corneal decompensation is a serious complication that appears to be directly related to pIOLs. Corneal decompensation can occur up to 13 years following implantation of pIOLs, and long-term follow-up is important to monitor for this complication.
Keywords: Artisan lens; Verisyse lens; cataract; corneal decompensation; phakic IOL.
Figures
Similar articles
- Visual Prognosis Following Cataract Surgery in Highly Myopic Patients with Prior History of Verisyse Phakic Intraocular Lens Implantation.Loveless BA, Moin KA, Moshirfar M, Olson TV, Hoopes PC.Loveless BA, et al.J Clin Med. 2024 Aug 13;13(16):4760. doi: 10.3390/jcm13164760.J Clin Med. 2024.PMID:39200902Free PMC article.
- Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.Medical Advisory Secretariat.Medical Advisory Secretariat.Ont Health Technol Assess Ser. 2009;9(14):1-120. Epub 2009 Oct 1.Ont Health Technol Assess Ser. 2009.PMID:23074518Free PMC article.
- Cataract surgery following phakic intraocular lens implantation.Moshirfar M, Mifflin M, Wong G, Chang JC.Moshirfar M, et al.Curr Opin Ophthalmol. 2010 Jan;21(1):39-44. doi: 10.1097/ICU.0b013e328333ea2f.Curr Opin Ophthalmol. 2010.PMID:19890209Review.
- Phakic intraocular lens explantation: causes in 240 cases.Alió JL, Toffaha BT, Peña-Garcia P, Sádaba LM, Barraquer RI.Alió JL, et al.J Refract Surg. 2015 Jan;31(1):30-5. doi: 10.3928/1081597X-20141202-01. Epub 2014 Dec 9.J Refract Surg. 2015.PMID:25486676
- Phakic intraocular lenses: An overview.Jonker SMR, Berendschot TTJM, Saelens IEY, Bauer NJC, Nuijts RMMA.Jonker SMR, et al.Indian J Ophthalmol. 2020 Dec;68(12):2779-2796. doi: 10.4103/ijo.IJO_2995_20.Indian J Ophthalmol. 2020.PMID:33229653Free PMC article.Review.
Cited by
- Iris-Claw Anterior Chamber Phakic Intraocular Lens Explantation: A Case Series.Teixeira SC, Martins P, Pacheco T, Arede C.Teixeira SC, et al.J Curr Ophthalmol. 2024 Aug 10;35(4):332-336. doi: 10.4103/joco.joco_137_23. eCollection 2023 Oct-Dec.J Curr Ophthalmol. 2024.PMID:39281391Free PMC article.
- Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®).Galvis V, Villamil JF, Acuña MF, Camacho PA, Merayo-Lloves J, Tello A, Zambrano SL, Rey JJ, Espinoza JV, Prada AM.Galvis V, et al.Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2775-2787. doi: 10.1007/s00417-019-04506-9. Epub 2019 Oct 28.Graefes Arch Clin Exp Ophthalmol. 2019.PMID:31659458
- Verisyse versus Veriflex Phakic Intraocular Lenses: Refractive Outcomes and Endothelial Cell Density 5 Years after Surgery.Yaşa D, Ağca A.Yaşa D, et al.J Ophthalmol. 2018 Sep 30;2018:4210460. doi: 10.1155/2018/4210460. eCollection 2018.J Ophthalmol. 2018.PMID:30363928Free PMC article.
- Visual Prognosis Following Cataract Surgery in Highly Myopic Patients with Prior History of Verisyse Phakic Intraocular Lens Implantation.Loveless BA, Moin KA, Moshirfar M, Olson TV, Hoopes PC.Loveless BA, et al.J Clin Med. 2024 Aug 13;13(16):4760. doi: 10.3390/jcm13164760.J Clin Med. 2024.PMID:39200902Free PMC article.
- Two-year results after combined phacoemulsification and iris-fixated phakic intraocular lens removal.Gaurisankar ZS, van Rijn GA, Cheng YYY, Luyten GPM, Beenakker JM.Gaurisankar ZS, et al.Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1367-1375. doi: 10.1007/s00417-021-05442-3. Epub 2021 Oct 16.Graefes Arch Clin Exp Ophthalmol. 2022.PMID:34655334Free PMC article.
References
- Gonnermann J, Klamann MK, Maier AK, et al. Visual outcome and complications after posterior iris-claw aphakic intraocular lens implantation. J Cataract Refract Surg. 2012;38(12):2139–2143. - PubMed
- Güell JL, Morral M, Gris O, Gaytan J, Sisquella M, Manero F. Five-year follow-up of 399 phakic Artisan-Verisyse implantation for myopia, hyperopia and/or astigmatism. Ophthalmology. 2008;115(6):1002–1012. - PubMed
- Moshirfar M, Holz HA, Davis DK. Two-year follow-up of the Artisan/Verisyse iris-supported phakic intraocular lens for the correction of high myopia. J Cataract Refract Surg. 2007;33(8):1392–1397. - PubMed
- Stulting RD, John ME, Maloney RK, Assil KK, Arrowsmith PN, Thompson VM. Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Ophthalmology. 2008;115(3):464–472. - PubMed
- Coullet J, Mahieu L, Malecaze F, et al. Severe endothelial cell loss following uneventful angle-supported phakic intraocular lens implantation for high myopia. J Cataract Refract Surg. 2007;33(8):1477–1481. - PubMed
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources